Spring 2025
By Samantha Sullivan
Photography by Armond Feffer/Boston Red Sox
For nearly a decade, active recovery footwear brand OOFOS has supported breast cancer research at Dana-Farber through its Project Pink initiative, which donates a percentage of online sales to the Institute. In 2024, the organization surpassed an impressive $4 million in all-time donations to help find new cures and treatments.
Since its launch in 2015, Project Pink has been a beacon of hope for patients with breast cancer. Project Pink was inspired by OOFOS brand leader and marketing director Duncan Finigan, who was diagnosed with stage IV breast cancer in 2014 and received treatment at Dana-Farber. When she shared her diagnosis with her OOFOS family, the company was determined to make an impact in the fight against breast cancer, leading to the launch of Project Pink. Although Finigan passed away in 2019, her spirit lives on through OOFOS’ unwavering commitment to advancing breast cancer research and care.
“This milestone achievement is just the beginning for us, and we look forward to our continued support for such an incredible organization.”
Lou Panaccione, OOFOS
“Project Pink is an incredibly special part of our company,” said Lou Panaccione, co-founder and CEO at OOFOS. “Every cent raised is a testament to Duncan’s legacy, and we are so proud to honor her while making an impact for other cancer patients. This milestone achievement is just the beginning for us, and we look forward to our continued support for such an incredible organization.”
According to the American Cancer Society, more than 313,500 people will be diagnosed with invasive breast cancer in the U.S. this year, representing 15.5% of all new cancer cases. “We know breast cancer is an incredibly complex disease, and no two cases are the same. At Dana-Farber, we’re determined to provide personalized treatment options so that we can provide each patient with the optimal care,” said Sara Tolaney, MD, MPH, chief of the Division of Breast Oncology in the Susan F. Smith Center for Women’s Cancers at Dana-Farber. “Thanks to OOFOS, we are able to make incredible strides in finding new treatments to help improve outcomes for breast cancer. We are so grateful to them and look forward to our continued partnership.”